14. EQUITY AND SHARE‑BASED COMPENSATION PLANS

Preferred Stock

Our Board is authorized to issue up to 2,000,000 shares of preferred stock and to determine the dividend rights and terms, redemption rights and terms, liquidation preferences, conversion rights, voting rights and sinking fund provisions of those shares without any further vote or act by Company shareholders. There was no issued preferred stock as of February 2, 2019 and February 3, 2018, respectively.

Stock Plans

In June 2016, our shareholders approved the Tailored Brands, Inc. 2016 Long-Term Incentive Plan (the “2016 LTIP”), which will be used for equity grants after June 2016. As amended in 2017, the 2016 LTIP provides for an aggregate of up to 9,300,000 shares, subject to adjustment, of our common stock (or the fair market value thereof) with respect to which stock options, stock appreciation rights, restricted stock, deferred stock units and performance based awards may be granted to full‑time key employees and to non‑employee directors of the Company.

In addition, we continue to administer the 2004 Long-Term Incentive Plan (the “2004 LTIP”) and the 1996 Long‑Term Incentive Plan (“1996 Plan”) as a result of awards which remain outstanding pursuant to such plans. Awards are no longer available for grant under the 2004 LTIP and 1996 Plan.

Stock options granted under these plans vest annually in varying increments over a period from one to three years and must be exercised within ten years of the date of grant. Grants of deferred stock units, performance units or restricted stock generally vest over a period from one to three years.

As of February 2, 2019, 6,612,534 shares were available for grant under the 2016 LTIP and 9,140,598 shares of common stock were reserved for future issuance under the existing plans.

Non‑Vested Deferred Stock Units, Performance Units and Restricted Stock

The following table summarizes the activity of time-based and performance-based (collectively, “DSUs”) awards during fiscal 2018:


			Weighted-Average
	Units		Grant-Date Fair Value
	Time-	Performance-	Time-		Performance-
	Based	Based	Based		Based
Non-Vested at February 3, 2018	1,014,689	993,631	$	18.13	$	19.55
Granted	686,433	254,895		26.25		28.33
Vested(1)	(603,394)	(180,997)		21.15		24.44
Forfeited	(158,642)	(730,623)		19.66		21.84
Non-Vested at February 2, 2019	939,086	336,906	$	22.60	$	18.59

(1)

Includes 284,220 shares relinquished for tax payments related to vested DSUs in fiscal 2018.

The following table summarizes additional information about DSUs:


	Fiscal Year
	2018		2017		2016
DSUs issued		941,328		1,015,236		1,315,140
Weighted average grant date fair value	$	26.81	$	11.47	$	18.61

The fair value of shares vested was $17.2 million, $11.6 million and $11.1 million in fiscal 2018, 2017 and 2016, respectively. As of February 2, 2019, the intrinsic value of non‑vested DSUs was $16.0 million. Grants of DSUs generally vest over a period of three years. DSUs earn dividends throughout the vesting period that are subject to the same vesting terms as the underlying awards.

The 254,895 performance units granted in 2018 represent a contingent right to earn shares of common stock, subject to the achievement of a Company-specific performance target for fiscal 2020. Assuming the performance target is achieved, 100% of the award will vest on the three year anniversary of the grant date. Performance units that are unvested at the end of the performance period will lapse and be forfeited. Performance units earn dividends throughout the vesting period that are subject to the same vesting terms as the underlying awards.

As of February 2, 2019, we have unrecognized compensation expense related to non‑vested DSUs of approximately $15.8 million which is expected to be recognized over a weighted‑average period of 1.4 years.

As of February 2, 2019 and February 3, 2018, there were no outstanding shares of restricted stock. The fair value of restricted stock that vested in fiscal 2017 and fiscal 2016 was $0.6 million and $0.7 million, respectively. During fiscal 2016, 18,646 shares of restricted stock were granted with a weighted average grant date fair value of $17.37.

Stock Options

The following table summarizes the activity of stock options during fiscal 2018:


		Weighted-		Remaining		Intrinsic
	Number of	Average		Contractual		Value
	Shares	Exercise Price		Term		(in thousands)
Outstanding at February 3, 2018	1,527,176	$	21.97
Granted	232,430		28.09
Exercised	(256,111)		19.22
Forfeited	(210,327)		16.42
Expired	(41,096)		51.18
Outstanding at February 2, 2019	1,252,072	$	23.64	7.2	Years	$	391
Vested and expected to vest at February 2, 2019	1,241,193	$	23.65	7.2	Years	$	387
Exercisable at February 2, 2019	676,059	$	28.33	6.2	Years	$	129

The weighted‑average grant date fair value of stock options granted during fiscal 2018, 2017 and 2016 was $10.29, $3.86 and $5.18, respectively. The fair value of stock options is estimated on the date of grant using the Black‑Scholes option pricing model using the following weighted‑average assumptions:



	Fiscal Year
	2018	2017	2016
Risk-free interest rate	2.70%	1.75%	1.22%
Expected lives	5.0 years	5.0 years	5.0 years
Dividend yield	4.21%	4.69%	4.13%
Expected volatility	56.55%	55.12%	47.95%

The risk‑free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. The expected lives represents the period of time the stock options are expected to be outstanding after their grant date. The dividend yield is based on the average of the annual dividend divided by the market price of our common stock at the time of declaration. The expected volatility is based on historical volatility of our common stock. The total intrinsic value of stock options exercised during fiscal 2018, 2017 and 2016 was $1.7 million, less than $0.1 million and $0.1 million, respectively. As of February 2, 2019, we have unrecognized compensation expense related to non‑vested stock options of approximately $2.2 million which is expected to be recognized over a weighted‑average period of 1.4 years.

Cash Settled Awards

During 2017, we granted stock-based awards to certain employees, which vest over a period of three years, and will be settled in cash ("cash settled awards"). The fair value of the cash settled awards at each reporting period is based on the price of our common stock and includes a market condition. The fair value of the cash settled awards will be remeasured at each reporting period until the awards are settled. At February 2, 2019, the liability associated with the cash settled awards was $3.8 million with $2.4 million recorded in accrued expenses and other current liabilities and $1.4 million recorded in other liabilities in the consolidated balance sheets. At February 3, 2018, the liability associated with the cash settled awards was $4.6 million with $2.8 million recorded in accrued expenses and other current liabilities and $1.8 million recorded in other liabilities in the consolidated balance sheets.

The following table summarizes the activity of cash settled awards during fiscal 2018 (in thousands):


	Cash Settled Awards
Non-Vested at February 3, 2018	$	8,353
Granted		—
Vested		(2,702)
Forfeited		(579)
Non-Vested at February 2, 2019	$	5,072

As of February 2, 2019, we have unrecognized compensation expense related to non‑vested cash settled awards of approximately $1.5 million which is expected to be recognized over a weighted‑average period of 1.0 years.